We are a pre-clinical medical device company specializing in

Transfemoral Mitral Valve Repair

for the treatment of Degenerative Mitral Regurgitation

We Focus

on degenerative mitral regurgitation (DMR), a very common human heart valve disease, and the development of effective and non-invasive medical technology to treat DMR

Our Goal

is non-invasive treatment of DMR with a novel medical device that uses the proven principles of mitral valve surgery - we provide surgical quality mitral valve repair, but with a catheter

What is Mitral Regurgitation?

Mitral regurgitation (MR) is the abnormal reverse flow of blood in the heart due to leakage through the mitral valve during each heartbeat. A common heart valve disease, MR affects about 5% of the population, and approximately 1% of patients will require medical treatment.

Degenerative MR (DMR) occurs when the valve itself is abnormal. DMR is preferably treated with valve repair.

DMR Statistics

0 %

of all people

0 %

of people over 70

0 M

cases in 2023

0 %

Mortality rate within 5yrs

The Vesalius Mission

To provide a safe, effective and non-invasive therapy for all DMR patients with an innovative medical device, thereby addressing a large unmet need in cardiovascular health

The Vesalius Features

Our Solution's Advantages

Contact Us For More Info

Our Transfemoral Repair for Degenerative Mitral Regurgitation represents a transformative advancement in heart disease treatment. If you’d like to learn more about this life-saving technology, please get in touch. You are not only contributing to better patient outcomes, but also getting involved with a rapidly growing market. Join us in revolutionizing heart care and seeing the benefits of a healthier future for millions.

latest news

News & Articles